PETALING JAYA: Duopharma Biotech Bhd aims to deliver a satisfactory performance in 2025, barring unforeseen market changes and developments. Read full...
Vous n'êtes pas connecté
PETALING JAYA: Duopharma Biotech Bhd, which released the company's fourth quarter ended Dec 31, 2024 (4Q24) and full-year financial results on Wednesday, is expected to see further earnings growth in FY25 on higher government healthcare allocation and lower active pharmaceutical ingredient (API) prices. Read full story
PETALING JAYA: Duopharma Biotech Bhd aims to deliver a satisfactory performance in 2025, barring unforeseen market changes and developments. Read full...
PETALING JAYA: Gas Malaysia Bhd is expected to deliver another solid quarterly earnings in its upcoming fourth quarter financial year 2024 (4Q24)...
Heineken Malaysia Bhd has delivered a record-high quarterly net profit of RM140.85mil in its fourth quarter ended Dec 31, 2024 (4Q24), a 42.2% jump...
PETALING JAYA: In the run-up to domestic banks releasing their fourth-quarter ended Dec 31, 2024 (4Q24) and full-year financial results in the coming...
KUALA LUMPUR: Duopharma Biotech Bhd is expected to see a brighter earnings outlook, driven by the government’s higher budget allocation for the...
PETALING JAYA: Electrical engineering service provider, HE Group Bhd (HEG) is confident of sustaining its growth momentum in the coming financial year...
PETALING JAYA: Electrical engineering service provider HE Group Bhd (HEG) is confident of sustaining its growth momentum in the coming financial year...
PETALING JAYA: Sunway Construction Group Bhd (SunCon) is optimistic of registering positive growth for the financial year ending 2025, based on our...
KUALA LUMPUR: Heineken Malaysia Bhd, which posted a 42.2% jump in net profit for the fourth quarter ended Dec 31 (4Q24), aims to sustain its growth...
CelcomDigi Bhd expects a stronger performance from its financial year ending Dec 31, 2025 (FY25) onwards, as integration costs and accounting...